Harmony Biosciences (HRMY) Tops Q1 EPS by 20c

Harmony Biosciences (NASDAQ: HRMY) reported Q1 EPS of $0.51, $0.20 better than the analyst estimate of $0.31. Revenue for the quarter came in at $85.3 million versus the consensus estimate of $89.61 million.

For earnings history and earnings-related data on Harmony Biosciences (HRMY) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Stifel downgrades Intuit to Hold on growth concerns, cuts target price
• Hyperscale Data launches $300M at-the-market stock offering